logo
Plus   Neg
Share
Email
Comment

EARNINGS SUMMARY: Details of Alnylam Pharmaceuticals Inc. Q4 Earnings Report

Below are the earnings highlights for Alnylam Pharmaceuticals Inc. (ALNY):

-Earnings: -$115.11 million in Q4 vs. -$92.28 million in the same period last year.
-EPS: -$1.20 in Q4 vs. -$1.08 in the same period last year.
-Revenue: $37.92 million in Q4 vs. $17.45 million in the same period last year.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

comments powered by Disqus
Follow RTT